90 Tumor infiltrating leukocyte subpopulations as a biomarker of response and resistance to targeted therapy in patients with BRAF mutation-positive metastatic melanoma
Mark C. Kelley(Vanderbilt University), Jonathan M. Irish(Vanderbilt University), Deon B. Doxie(Vanderbilt University), Allison R. Greenplate(California University of Pennsylvania), Holly Crandall, Jeff Sosman
Cited by 0
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|806